L. Pellowska-Januszek et al. / Carbohydrate Research 339 (2004) 1537–1544
1543
H-6a, J6a;6b 11.6 Hz), 4.78 (dd, 1H, H-6b), 4.36 (ddd, 1H,
H-5, J5;6a 2.4 Hz, J5;6b 7.6 Hz), 2.92 (s, 3H, –OCH3), 2.91
(s, 3H, PhCH3-picoline), 2.42 (s, 3H, PhCH3), 2.21–2.09
(9H, 3 · OAc); 13C NMR (H2O): d 173.40–172.72 (3C,
3 · OOCCH3), 146.48–125.60 (9C, Ph), 96.37 (C-1),
70.74 (C-2), 70.31 (C-3), 70.22 (C-4), 68.06 (C-5), 57.15
(C-6), 54.91 (–OCH3), 20.69 (PhCH3), 20.34–20.19 (3C,
COOCH3), 17.03 (PhCH3); Rf ¼ 0 (3:1 CHCl3–MeOH).
Anal. Calcd for C26H33NO11S (567.612): C, 55.02; H,
5.86; N, 2.47; S, 5.65; O, 31.00. Found: C, 55.54; H,
5.82; N, 2.72; S, 5.71. MALDITOF-MS (CCA): m=z
396.1 ([M)OTs]þ).
concentrated to an oil. The oil crystallized from AcOEt
to give the title compound; (72.4 mg, 62.5%); mp 163 °C,
20
D
1
½a )15.13 (c 0.37, H2O); H NMR (D2O): d 8.89–8.13
(m, 5H, Py), 7.72–7.38 (2d, each 2H, Ph), 5.38 (t, 1H, H-
3, J3;4 9.6 Hz), 5.11 (t, 1H, H-4, J4;5 9.6 Hz), 5.02 (m, 1H,
H-2), 4.98 (dd, br, 1H, H-6a), 4.79 (dd, 1H, H-6b), 4.61
(d, 1H, H-1, J1;2 8.0 Hz), 4.29 (ddd, 1H, H-5, J5;6a 2.8 Hz,
J5;6b 6.6 Hz), 3.32 (s, 3H, –OCH3), 2.42 (s, 3H, PhCH3),
2.21–2.02 (9H, 3 · OAc); 13C NMR (H2O): d 173.27–
172.89 (3C, 3 · OOCCH3), 147.06–125.61 (6C, Ph),
100.86 (C-1), 73.05 (C-3), 71.38 (C-5), 71.36 (C-2), 69.97
(C-4), 61.17 (C-6), 57.20 (OCH3), 20.70 (PhCH3), 20.38–
20.24 (3C, COOCH3); Rf ¼ 0 (3:1 CHCl3–MeOH).
Anal. Calcd for C25H31NO11S (553.585): C, 54.24; H,
5.65; N, 2.53; S, 5.79; O, 31.78. Found: C, 54.03; H,
5.84; N, 2.95; S, 5.90. MALDITOF-MS (CCA): m=z
382.1 ([M)OTs]þ).
3.6. N-(Methyl 2,3,4-tri-O-acetyl-6-deoxy-b-D-glucopyr-
anoside-6-yl)trimethylammonium tosylate (3b)
Solution of trimethylamine (33%) in EtOH (2.3 mL) was
added to methyl 6-O-p-toluenesulfonyl-b- -glucopyr-
D
anoside (104.2 mg, 0.300 mmol). The reaction mixture
was kept in a screw-capped ampoule under ultrasonic
conditions at rt for 20 h and then for 8 days at rt. The
reaction mixture was evaporated to the dryness. The oily
residue was dissolved in a mixture of pyridine (6.5 mL)
and Ac2O (6.5 mL). N-(Methyl 2,3,4-tri-O-acetyl-6-
3.8. N-(Methyl 2,3,4-tri-O-acetyl-6-deoxy-b-D-glucopyr-
anoside-6-yl)-2-methylpyridinium tosylate (5b)
Methyl 6-O-p-toluenesulfonyl b-D-glucopyranoside
(68.6 mg, 0.200 mmol) was dissolved in dry 2-methyl-
pyridine (0.64 mL). The solution was kept in a screw-
capped ampoule: first at rt for 6 weeks, next at 70 °C for
16 days. After that time the solvent was evaporated. The
oil was dissolved in pyridine (3 mL) and Ac2O (3 mL)
was added. After 24 h the solution was evaporated. The
residue was dissolved in H2O and extracted with CHCl3.
deoxy-b-D-glucopyranoside-6-yl)trimethylammonium
tosylate crystallized from the solution of pyridine and
20
Ac2O (52.6 mg, 33%); mp 210–220 °C; ½a )2.28 (c
D
0.175, H2O); 1H NMR (D2O): d 7.64–7.30 (2d, each 2H,
Ph), 5.28 (t, 1H, H-2, J2;3 9.4 Hz), 4.95 (t, 1H, H-3, J3;4
9.2 Hz), 4.93 (t, 1H, H-4, J4;5 8 Hz), 4.77 (d, 1H, H-1, J1;2
8 Hz), 4.39 (t, 1H, H-5, J5;6a 9.2 Hz;), 3.62 (dd, 1H, H-6a,
J6a;6b 10 Hz), 3.47 (s, 3H, –OCH3), 3.44 (dd, 1H, H-6b),
3.17 (s, 9H, N(CH3)3), 2.33 (s, 3H, PhCH3), 2.05–1.99
(9H, 3 · OAc); 13C NMR (H2O): d 173.24–172.66 (3C,
3 · OOCCH3), 142.68–139.77 (2C, Ph), 129.68–125.62
(2C, Ph), 100.69 (C-1), 73.08 (C-2), 71.06 (C-4), 69.66
(C-3), 68.20 (C-5), 66.12 (C-6), 57.68 (OCH3), 54.46 (9C,
N(CH3)3), 20.70 (PhCH3), 20.32–20.23 (3C, COOCH3);
Rf ¼ 0 (3:1 CHCl3–MeOH). Anal. Calcd for
C23H35NO11S (533.595): C, 51.77; H, 6.61; N, 2.63; S,
6.01; O, 32.98. Found: C, 51.65; H, 6.64; N, 2.69; S,
6.11. MALDITOF-MS (CCA): m=z 362.2 ([M)OTs]þ).
The aqueous layer was evaporated and dried over P2O5
20
D
to give title compound (64.6 mg, 58%); ½a )22.55 (c
1
0.51, H2O); H NMR (D2O): d 8.76–7.91 (m, 4H, Py),
7.71–7.37 (2d, each 2H, Ph), 5.37 (t, 1H, H-3, J3;4
9.6 Hz), 5.23 (t, 1H, H-4, J4;5 9.6 Hz), 5.03 (q, 1H, H-2,
J2;3 8.4 Hz), 4.91 (dd, 1H, H-6a, J6a;6b 12.4 Hz), 4.76 (dd,
1H, H-6b), 4.55 (d, 1H, H-1, J1;2 8.4 Hz), 4.28 (ddd, 1H,
H-5, J5;6a 2.4 Hz, J5;6b 7.6. Hz), 3.28 (s, 3H, –OCH3), 2.90
(s, 3H, CH3-picoline), 2.41 (s, 3H, PhCH3), 2.21–2.10
(9H, 3 · OAc); 13C NMR (H2O): d 173.29–172.84 (3C,
3 · OOCCH3), 156.36–125.60 (9C, Ph), 100.73 (C-1),
73.13 (C-3), 71.38 (C-5), 71.32 (C-2), 70.39 (C-4), 57.47
(C-6), 57.10 (OCH3), 20.66 (PhCH3), 20.33–20.27 (3C,
COOCH3), 20.06 (1C, CH3-picoline); Rf ¼ 0 (3:1
CHCl3–MeOH). Anal. Calcd for C25H31NO11S
(553.585): C, 54.24; H, 5.65; N, 2.53; S, 5.79; O, 31.78.
Found: C, 54.34; H, 5.57; N, 2.49; S, 5.83. MALDI-
TOF-MS (CCA): m=z 396.1 ([M)OTs]þ).
3.7. N-(Methyl 2,3,4-tri-O-acetyl-6-deoxy-b-D-glucopyr-
anoside-6-yl)pyridinium tosylate (4b)
Methyl
6-O-p-toluenesulfonyl-b-D-glucopyranoside
(72.8 mg, 0.210 mmol) and a catalytic amount of phenol
were placed in a screw-capped ampoule. The reactant
and catalyst were dissolved in dry pyridine (0.55 mL).
The solution was kept in a screw-capped ampoule and
heated at 70 °C for 3 days. After that time the solution
was evaporated to dryness, and the residue was dis-
solved in a mixture of pyridine (3 mL) and Ac2O (3 mL).
After 24 h the solution was evaporated to dryness. The
residue was dissolved in H2O, extracted with CHCl3 and
4. Supplementary material
Full crystallographic details, excluding structure factors,
have been deposited (deposition no. CCDC 222217)
with the Cambridge Crystallographic Data Centre.
These data may be obtained, on request, from the